Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients

BACKGROUND. Hodgkin lymphoma (HL) is characterized by the presence of CD30-positive Hodgkin Reed-Sternberg cells. Approximately 30%–40% of patients with advanced disease are refractory to frontline therapy or will relapse after first-line treatment. The standard management of these patients is salva...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Zinzani, Pier Luigi, Pellegrini, Cinzia, Cantonetti, Maria, Re, Alessandro, Pinto, Antonello, Pavone, Vincenzo, Rigacci, Luigi, Celli, Melania, Broccoli, Alessandro, Argnani, Lisa, Pulsoni, Alessandro
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2015
Témata:
Hematologic Malignancies
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679088/
https://ncbi.nlm.nih.gov/pubmed/26500229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0227
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky